Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SB's new dopamine D3 receptor modulators particularly useful for schizophrenia

April 20, 2000

Diacrin puts phase I stroke trial on hold

April 19, 2000

Putative GABA mimetics designed by Warner-Lambert

April 19, 2000

Cannabinoid receptor antagonists from Aventis described for CNS and other conditions

April 19, 2000

CEP-4143, a new calpain antagonist, affords neuroprotection in rats with traumatic SCI

April 19, 2000

IGT Pharma adds to neuropharmaceutical patent filings

April 18, 2000

Subjects with sleep apnea being recruited for multicenter study

April 18, 2000

Trials demonstrate efficacy, safety and freedom from dependency for novel narcolepsy therapy

April 18, 2000

Anxiolytic-like effects demonstrated for human ORL1 receptor agonist

April 17, 2000

Parkinson's disease patients may benefit from implanted porcine embryonic cells

April 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...